Medpace Holdings, Inc. (MEDP)
600.65
-10.92
(-1.79%)
USD |
NASDAQ |
Aug 28, 16:00
599.44
-1.21
(-0.20%)
After-Hours: 20:00
Medpace Holdings Cash from Operations (Quarterly) : 162.01M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 162.01M |
| March 31, 2026 | 151.79M |
| December 31, 2025 | 192.65M |
| September 30, 2025 | 246.21M |
| June 30, 2025 | 148.53M |
| March 31, 2025 | 125.84M |
| December 31, 2024 | 190.67M |
| September 30, 2024 | 149.08M |
| June 30, 2024 | 116.40M |
| March 31, 2024 | 152.68M |
| December 31, 2023 | 156.40M |
| September 30, 2023 | 114.38M |
| June 30, 2023 | 82.52M |
| March 31, 2023 | 80.08M |
| December 31, 2022 | 136.68M |
| September 30, 2022 | 108.49M |
| June 30, 2022 | 96.62M |
| March 31, 2022 | 46.26M |
| December 31, 2021 | 70.89M |
| September 30, 2021 | 72.35M |
| June 30, 2021 | 62.76M |
| March 31, 2021 | 57.32M |
| December 31, 2020 | 105.50M |
| Date | Value |
|---|---|
| September 30, 2020 | 59.76M |
| June 30, 2020 | 44.27M |
| March 31, 2020 | 49.15M |
| December 31, 2019 | 56.94M |
| September 30, 2019 | 64.29M |
| June 30, 2019 | 46.63M |
| March 31, 2019 | 34.00M |
| December 31, 2018 | 39.44M |
| September 30, 2018 | 52.50M |
| June 30, 2018 | 41.34M |
| March 31, 2018 | 23.30M |
| December 31, 2017 | 28.65M |
| September 30, 2017 | 39.00M |
| June 30, 2017 | 30.41M |
| March 31, 2017 | -0.675M |
| December 31, 2016 | 29.06M |
| September 30, 2016 | 42.18M |
| June 30, 2016 | 7.866M |
| March 31, 2016 | 12.62M |
| December 31, 2015 | 27.24M |
| September 30, 2015 | 31.77M |
| June 30, 2015 | 26.87M |
| March 31, 2015 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 558.00M |
| Charles River Laboratories International, Inc. | 179.72M |
| Avantor, Inc. | 178.20M |
| Champions Oncology, Inc. | -1.998M |
| Personalis, Inc. | -25.77M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -23.88M |
| Cash from Financing (Quarterly) | -288.34M |
| Free Cash Flow | 706.69M |
| Free Cash Flow Per Share (Quarterly) | 4.836 |
| Free Cash Flow to Equity (Quarterly) | 140.08M |
| Free Cash Flow to Firm (Quarterly) | 138.10M |
| Free Cash Flow Yield | 4.08% |